These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16627464)

  • 21. Should we advise patients with serious mental illness to stop using cannabis?
    Grech A
    Psychol Med; 2008 Mar; 38(3):459; author reply 462-4. PubMed ID: 18298877
    [No Abstract]   [Full Text] [Related]  

  • 22. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The ignorance of cannabis toxic effects, why should we fight it?].
    Tillement JP
    Ann Pharm Fr; 2009 Jan; 67(1):54-5. PubMed ID: 19152851
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hazards of cannabis consumption].
    Uchtenhagen A
    Dtsch Med Wochenschr; 1996 Mar; 121(10):321. PubMed ID: 8681717
    [No Abstract]   [Full Text] [Related]  

  • 25. [Induced psychiatric and somatic disorders to cannabis].
    Laqueille X; Launay C; Kanit M
    Ann Pharm Fr; 2008 Aug; 66(4):245-54. PubMed ID: 18847572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cannabis: the approach must be scientific].
    Reynaud M
    Rev Prat; 2005 Jan; 55(1):14-6. PubMed ID: 15801391
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence.
    McSherry JW
    Neurology; 2005 Oct; 65(7):1145; author reply 1145. PubMed ID: 16217086
    [No Abstract]   [Full Text] [Related]  

  • 28. The coherence of the evidence linking cannabis with psychosis.
    Henquet C; Van Os J
    Psychol Med; 2008 Mar; 38(3):461-2; author reply 462-4. PubMed ID: 18298878
    [No Abstract]   [Full Text] [Related]  

  • 29. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users.
    Nestor L; Roberts G; Garavan H; Hester R
    Neuroimage; 2008 Apr; 40(3):1328-39. PubMed ID: 18296071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Legalization of cannabis: between political irresponsibility and loss of responsibility of psychiatrists].
    Bersani G; Iannitelli A
    Riv Psichiatr; 2015; 50(5):195-8. PubMed ID: 26489068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizotypy, marijuana, and differential item functioning.
    Earleywine M
    Hum Psychopharmacol; 2006 Oct; 21(7):455-61. PubMed ID: 16953519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brain damage and marihuana].
    Carranza-Acevedo J
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():187-94. PubMed ID: 4548640
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.
    Rentzsch J; Penzhorn A; Kernbichler K; Plöckl D; Gómez-Carrillo de Castro A; Gallinat J; Jockers-Scherübl MC
    Exp Neurol; 2007 May; 205(1):241-9. PubMed ID: 17368620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent use and misuse of marijuana.
    Foley JD
    Adolesc Med Clin; 2006 Jun; 17(2):319-34. PubMed ID: 16814696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
    Flanders SE
    Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
    Costentin J
    Ann Pharm Fr; 2008 Aug; 66(4):219-31. PubMed ID: 18847570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.